- Home
- BAND vs SION Comparison
BAND vs SION Comparison
Compare BAND & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAND
- SION
- Stock Information
- Founded
- BAND 2000
- SION 2019
- Country
- BAND United States
- SION United States
- Employees
- BAND 1100
- SION N/A
- Industry
- BAND Computer Software: Prepackaged Software
- SION
- Sector
- BAND Technology
- SION
- Exchange
- BAND Nasdaq
- SION NYSE
- Market Cap
- BAND 358.3M
- SION 338.0M
- IPO Year
- BAND 2017
- SION 2025
- Fundamental
- Price
- BAND $11.87
- SION $11.82
- Analyst Decision
- BAND Buy
- SION Strong Buy
- Analyst Count
- BAND 7
- SION 1
- Target Price
- BAND $27.17
- SION $32.00
- AVG Volume (30 Days)
- BAND 299.0K
- SION 178.4K
- Earning Date
- BAND 05-07-2025
- SION 05-25-2025
- Dividend Yield
- BAND N/A
- SION N/A
- EPS Growth
- BAND N/A
- SION N/A
- EPS
- BAND N/A
- SION N/A
- Revenue
- BAND $748,487,000.00
- SION N/A
- Revenue This Year
- BAND $1.85
- SION N/A
- Revenue Next Year
- BAND $13.76
- SION N/A
- P/E Ratio
- BAND N/A
- SION N/A
- Revenue Growth
- BAND 24.52
- SION N/A
- 52 Week Low
- BAND $11.45
- SION $7.26
- 52 Week High
- BAND $25.02
- SION $25.19
- Technical
- Relative Strength Index (RSI)
- BAND 32.16
- SION N/A
- Support Level
- BAND $11.33
- SION N/A
- Resistance Level
- BAND $13.30
- SION N/A
- Average True Range (ATR)
- BAND 0.72
- SION 0.00
- MACD
- BAND -0.01
- SION 0.00
- Stochastic Oscillator
- BAND 8.26
- SION 0.00
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.